Transition Therapeutics Inc. (TTH)
Interview with: Dr. Tony Cruz, Chairman and CEO
Business News, Financial News, Stocks, Money & Investment Ideas, CEO Interview
and Information on their innovative Islet Neogenesis
Therapy (I.N.T.TM) that offers a promising and exciting therapeutic alternative
to insulin-dependent diabetics. |
Cover Story
CEOCFO
Interview Index
CEOCFO Current
Issue
Future Features
Analyst Interviews
Corporate
Financials
Archived Interviews
About CEOCFOinterviews.com
Contact
& Ordering |
Transition Therapeutics – with one
of the leading regenerative therapies for the treatment of diabetes currently in Phase I
clinical trials
Healthcare
Biotechnology
(TTH – TSX venture)
Transition Therapeutics Inc.
Dr. Tony Cruz
Chairman and
Chief Executive Officer
Interview conducted by:
Lynn Fosse
Editor
CEOCFOinterviews.com
May 2003
Instant Access:
To find out more about:
Transition
Therapeutics Inc. (TTH)
you may order the complete text of our
interview. To receive a copy of this highly informative interview, left
click here: ViewTTH
disclaimer
|
